chatsimple
The logo for the medical devices company
Back to all AI Solutions

ProFound AI Breast Health Suite

ProFound AI precisely identifies subtle, early lesions and scores the case for an overall suspicion of cancer, while also reporting density and risk stratification.

Backed by clinical evidence, proven outcomes, and thousands of global users, ProFound AI delivers unmatched accuracy, multi-vendor compatibility, and workflow advantages, empowering earlier cancer detection and transforming lives.

ProFound Detection V4 is FDA Cleared. ProFound AI V3 and PowerLook Density Assessment are FDA Cleared, CE Marked, and Health Canada Licensed. ProFound AI Risk is CE Marked and Health Canada Licensed. Products may not be available in all geographies.

Key benefits

  • 8.4% Improvement in sensitivity
  • 7.2% Reduction in recall rate
  • 52% Reduction in reading time
  • 88.1% AUC Specificity/Sensitivity

Details

  • Regulatory:
MMG
Breast
Senology
Oncology
CE
FDA
TGA
  • Clinical Applications:
MMG
Breast
Senology
Oncology
CE
FDA
TGA
  • Modality:
MMG
Breast
Senology
Oncology
CE
FDA
TGA
  • Body Part:
MMG
Breast
Senology
Oncology
CE
FDA
TGA

Peer-reviewed publications

Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis Read